Roche stock drops 5% after report its Wegovy challenger is causing patients to vomitRoche's obesity pill faces challenges with side effects that may impact its competitive edge in the weight-loss pharmaceutical market.
Lilly sells Zepbound vials at 50% discount to meet weight loss drug demandEli Lilly launches Zepbound vials at lower prices to address supply shortages and boost access for patients.
The economic disaster of extra pounds: Pharmaceutical companies are profiting in an increasingly obese worldMore than 1.5 billion adults and almost 400 million children will be living with obesity within 12 years if the condition isn't stopped.The economic impact of obesity in the world will reach $4.32 trillion in losses annually by 2035.Pharmaceutical companies see the fight against obesity as a lucrative market.